Symplr Appoints Healthcare Software Veterans Mike Valli As Chief Commercial Officer & Scott Sbihli As Chief Product Officer
Sbihli is a seasoned healthcare technologist with over 25 years of product management, innovation and executive leadership experience. As CPO, he will oversee symplr's product strategy, portfolio and roadmap, ensuring these are integrated and optimized within the broader symplr Operations Platform, helping customers to consolidate systems and create cross-enterprise workflows. He joins symplr from Inovalon where he served as Senior Vice President of Product Management, overseeing quality, risk, member outreach, and data lake/AI solutions for payers. Prior to Inovalon, Sbihli held payer and provider product leadership roles at HealthEdge and Nuance Communications.
"We're confident that the industry experience Mike and Scott bring will accelerate our enterprise strategy supported by our symplr Operations Platform," said BJ Schaknowski, CEO of symplr . "They'll be working to make sure that every touchpoint, from initial engagement to ongoing platform use, not only unlocks real value for customers, but also drives symplr's long-term growth by strengthening customer adoption and expanding our market presence."
About symplr
symplr is a leader in enterprise healthcare operations software and services with a first-of-its-kind operations platform. Trusted in 9 of 10 U.S. hospitals and 400+ U.S. health plans, symplr optimizes operations and maximizes care powered by our cloud-based workforce, quality, provider data management, and spend solutions. Gain efficiencies, reduce complexity and improve outcomes where it matters most. Learn how to stay ahead of change at .
SOURCE symplr
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment